Alternative RNA splicing in the nervous system

被引:346
作者
Grabowski, PJ
Black, DL
机构
[1] Univ Pittsburgh, Dept Biol Sci, Howard Hughes Med Inst, Pittsburgh, PA 15260 USA
[2] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA
关键词
D O I
10.1016/S0301-0082(01)00007-7
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Tissue-specific alternative splicing profoundly effects animal physiology, development and disease. and this is nowhere more evident than in the nervous system. Alternative splicing is a versatile form of genetic control whereby a common pre-mRNA is processed into multiple mRNA isoforms differing in their precise combination of exon sequences. In the nervous system, thousands of alternatively spliced mRNAs are translated into their protein counterparts where specific isoforms play roles in learning and memory. neuronal cell recognition, neurotransmission, ion channel function, and receptor specificity. The essential nature of this process is underscored by the finding that its misregulation is a common characteristic of human disease. This review highlights the current views of the biological phenomenon of alternative splicing, and describes evidence for its intricate underlying biochemical mechanisms. The roles of RNA binding proteins and their tissue-specific properties are discussed. Why does alternative splicing occur in cosmic proportions in the nervous system? How does it affect integrated cellular functions? How are region-specific, cell-specific and developmental differences in splicing directed? How are the control mechanisms that operate in the nervous system distinct from those of other tissues? Although there are many unanswered questions, substantial progress has been made in showing that alternative splicing is of major importance in generating proteomic diversity, and in modulating protein activities in a temporal and spatial manner. The relevance of alternative splicing to diseases of the nervous system is also discussed. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:289 / 308
页数:20
相关论文
共 185 条
[1]
ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells [J].
Antic, D ;
Lu, N ;
Keene, JD .
GENES & DEVELOPMENT, 1999, 13 (04) :449-461
[2]
Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression [J].
Antic, D ;
Keene, JD .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) :273-278
[3]
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis [J].
Aoki, M ;
Lin, CLG ;
Rothstein, JD ;
Geller, BA ;
Hosler, BA ;
Munsat, TL ;
Horvitz, HR ;
Brown, RH .
ANNALS OF NEUROLOGY, 1998, 43 (05) :645-653
[4]
Ashiya M, 1997, RNA, V3, P996
[5]
Atasoy U, 1998, J CELL SCI, V111, P3145
[6]
EXON RECOGNITION IN VERTEBRATE SPLICING [J].
BERGET, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) :2411-2414
[7]
Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology [J].
Black, DL .
CELL, 2000, 103 (03) :367-370
[9]
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[10]
BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608